Home - Gastroenterology Advisor
WEBFDA Alert: Gastroenterology Drug Approvals and New Indications. The FDA approved a biosimilar for inflammatory bowel diseases and issued several new indications for nonerosive GERD, UC, and PFIC.
Clinician Insights on How to Manage Semaglutide-Induced …
WEBSep 8, 2023 · Two clinicians weigh in on the link between semaglutide and gastroparesis and how to help patients manage symptoms.
What We Know About Semaglutide Adverse Events and …
WEBSep 1, 2023 · Recent reports of severe semaglutide adverse events, such as gastroparesis, have raised concerns about the drug used for weight loss and type 2 diabetes.
Assessment of Antispasmodics Available in North America for the ...
WEBOct 15, 2021 · Safety and efficacy data on use of antispasmodics in patients with disorders of gut-brain interaction being treated for chronic abdominal pain vary dramatically.
Gastroparesis Awareness Month: Updated Guidelines to Treat …
WEBAug 19, 2022 · For the first time since 2013, the American College of Gastroenterology has released updated recommendations for managing gastroparesis.
Gastric Intestinal Metaplasia: 2020 AGA Guidelines
WEBMar 12, 2020 · The American Gastroenterological Association recently published new clinical practice guidelines on the management of gastric intestinal metaplasia.
Chronic Idiopathic Constipation: 10 Recommendations for …
WEBJun 9, 2023 · Polyethylene glycol, plecanatide, and linaclotide are among the AGA and ACG recommended treatment options for chronic idiopathic constipation.
Taking GLP-1RAs for Weight Loss May Increase Risk for …
WEBMay 18, 2024 · Receiving treatment with GLP-1RAs for weight loss is associated with gastroparesis onset among patients with obesity and without diabetes.
2021 American College of Gastroenterology Guidelines: Upper ...
WEBJun 2, 2021 · The American College of Gastroenterology released clinical guidelines on upper gastrointestinal and ulcer bleeding using an evidence-based approach.
Novel Drug Tradipitant Effective, Safe for Treatment of Nausea in ...
WEBOct 29, 2021 · Tradipitant appears to be an effective and safe treatment option for gastroparesis symptoms, according to research presented at the American College of Gastroenterology (ACG) 2021 Annual Meeting, held from October 22 to 27, 2021, in Las Vegas, Nevada and virtually. The present analysis used data from the open-label extension (OLE) phase of a 4-week, phase 2 trial of tradipitant for the ...